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Muscular hypertrophyAbstract We report a 2.5 year old male, ﬁrst in order of birth of ﬁrst cousin consanguineous par-
ents with the typical features of Berardinelli–Seip congenital lipodystrophy 2 (BSCL2) since birth
with moderate mental retardation. He had generalized lipodystrophy with various dermatologic
and systemic manifestations. The patient looked older than his age with the loss of buccal pad of
fat, hypertrichosis mainly on the back and lower limbs, thick scalp hair, mild prognathism, large
hands and feet with prominent joints and muscular hypertrophy. Acanthosis nigricans was evident
over the neck and both axillae inspite of the normal level of sugar and insulin. The abdomen was
markedly prominent with mild hepatosplenomegaly and enlarged external genitals. Echo-cardiog-
raphy demonstrated cardiac hypertrophy. Triglyceride level was high with reduced high density
lipoproteins (HDL).
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Lipodystrophies represent a heterogeneous group of rare dis-
eases characterized by generalized or partial alterations in body
fat development or distribution [1]. Lipodystrophies are most
often characterized by selective loss of the adipose tissue from
particular anatomical regions, ranging from localized to gener-
alized [1]. Patients with lipodystrophy often have some of the
metabolic disturbances such as increased visceral fat, dyslipide-
mia, and insulin resistance [2]. Lipodystrophies can be classiﬁed
into ‘‘familial’’ or ‘‘genetic’’ and ‘‘acquired’’ types [3] and can
also be a component of certain rare inherited multi-system syn-
dromes [1]. Congenital generalized lipodystrophy (CGL) of theBerardinelli–Seip type (BSCL) is a rare genetic condition char-
acterized by a near total absence of the adipose tissue [4]. Fat
cells are present, but are reduced in number and size and con-
tain little fat [5]. It was ﬁrst described more than a half-century
ago by Berardinelli and later by Seip [6]. Patients are character-
ized by accelerated linear growth, advanced bone age, and
marked acanthosis nigricans [4,7]. In addition, umbilical her-
nia, hepatomegaly secondary to hepatic steatosis that can pro-
gress to cirrhosis, splenomegaly, [4,7,8] cardiomyopathy and
mental retardation may variably occur [9,10].
There are approximately more than 250 cases of various
ethnic origins reported all over the world, with greater fre-
quency in some ethnic groups, mainly in Latin Americans
and Arabians [11].
Here we report an Egyptian child with BSCL most probably
belonging to type 2 with visceral and dermatologic manifesta-
tions in view of its rarity, after taking consent of the parents.
Figure 2 Large hands with enlarged interphalangeal joints.
Figure 3 Generalized lipoatrophy, muscular hypertrophy,
hypertrichosis, and large joints.
Figure 4 Acanthosis nigricans in the neck.
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The case of a 2.5 year old male, ﬁrst in order of birth of ﬁrst
cousin consanguineous Egyptian parents is reported. The
patient was delivered at full term by vaginal delivery after
uncomplicated pregnancy. His birth weight was 3 kg. The
patient was referred to the Genetics Clinic, Pediatric Hospital,
Ain Shams University complaining of unusual facial features.
Since birth the mother noticed that her son was born with
empty cheeks. At the age of 6 months, there was a gradual
increase in the abdominal size. His parents were normal. His
motor development was appropriate for age with mild deﬁcits
in mental and communication skills.
On examination, his weight was 14 kg (on 75th percentile),
his height was 95 cm (on 90th percentile), and his skull circum-
ference was 47 cm (on 10th percentile). The patient looked
older than his age. He had generalized loss of subcutaneous
fat, hypertrichosis in the back, thighs and legs, thick scalp hair,
low anterior hair line, prominent frontal and supraorbital
ridges, loss of buccal fat, decayed teeth, mild prognathism,
large low set ears, large hands with tall ﬁngers and clinodactyly
of 5th ﬁngers and hypertrophied proximal interphalangeal
joints. The feet were large with long toes and the second and
the fourth toes overriding the third toe. There was mild hyper-
trophy of muscles in the calf and the thigh and loss of buttocks
fat (Figs. 1–3). He also had thick hyperpigmented patchy areas
(acanthosis nigricans) in the neck and both axillae (Fig. 4).
Abdominal examination revealed divarication of recti, pro-
tuberant abdomen with the liver spanning 7 cm, non tender,
ﬁrm in consistency, with sharp border, and smooth surface
(Fig. 5). The spleen was 2 cm enlarged along its long axis, ﬁrm
in consistency and non-tender. Cardiac examination was
apparently normal. The back was normal. The genitals demon-
strated penile hypertrophy (Fig. 3). Neurologic examination
demonstrated normal tone with elicited reﬂexes.
Lipid proﬁle showed a normal serum cholesterol of 170 mg/
dl (N: up to 200 mg/dl), a normal Low-density lipoprotein
(LDL) of 102 mg/dl (N: <130 mg/dl) and a reduced HDL
33 mg/dl (N >35 mg/dl) and elevation in triglyceride level
176 (N: 70–160 mg/dl).
Fasting blood sugar was within normal limits 81 mg/dl. (N:
70–110 mg/dl). Liver and kidney functions were also within
normal levels.
Abdomino-pelvic ultrasonography revealed mild
hepatosplenomegaly and cystitis. ECHO cardiography
revealed concentric hypertrophy of interventricular septumFigure 1 Prominent orbital ridges, loss of buccal fat, decayed
teeth and slight prognathism.
Figure 5 Protuberant abdomen.
Figure 6 Cardiomegaly in X-ray chest.
Figure 7 X-ray wrist shows normal bone age.
Berardinelli–Seip syndrome type 2 191and left ventricular posterior wall without left ventricular out-
ﬂow tract obstructions. Chest X-ray revealed cardiomegaly
(Fig. 6). X-ray of upper and lower limbs demonstrated normal
bones and normal bone age (Figs. 7 and 8). Serum creatine
kinase as well as insulin levels were normal. Liver function
tests were normal.
3. Discussion
We report a 2.5 year old male patient, with features typical of
BSCL. It was suggested that the presence of 3 major or 2 majorFigure 8 X-ray upper and loweas well as 2 minor criteria conforms to the diagnosis of BSCL
[12].
Major criteria include 1 – Generalized lipoatrophy involv-
ing the trunk, limbs and face. 2 – Acromegaloid features with
gigantism, prognathism, prominent orbital ridges, enlarged
hands and feet, muscular hypertrophy, advanced bone age,
clitoromegaly in females and enlarged genitalia in males. 3 –
Hepatomegaly. 4 – Elevated serum triglycerides. 5 – Insulin
resistance.
Minor criteria include 1 – Hypertrophic cardiomyopathy
detected in infancy or later in life. 2 – Psychomotor retardation
or mild to moderate intellectual impairment. 3 – Hirsutism
with low frontal and posterior hair lines. 4 – Precocious
puberty in females. 5 – Bone cysts often diagnosed in the
2nd decade of life.
Our patient had 4 major criteria and 3 minor criteria, so he
conforms to the diagnosis of BSCL.
There is a generalized absence of fat due to defects in adipo-
genesis pathway together with increased destruction of adipo-
cytes as well as inability of adipocytes to store fat [13].
Adipocytes are unable to synthesize and release adipocytokines
(leptin and adiponectin), which show decreased levels. Leptin
deﬁciency can lead to decreased metabolic rate, voracious appe-
tite and worsening of metabolic rate. Both leptin and adiponec-
tin deﬁciency lead to decreased storage of fat in the adipose
tissue, deposition of excess fat in liver and muscles, decreased
fatty acid oxidation in the skeletal muscles and in the liver,
decreased glucose uptake and hepatic gluconeogenesis [14].
The acromegalic appearance of our patient was evidenced
by prognathism and enlarged hands, feet, nose and ears.
Although growth hormone level was reported to be normal
in these patients, insulin like growth factor hypersecretion
was found which leads to anabolic processes with rapid skele-
tal maturation [1]; however our patient had normal bone age.
Our patient had decayed teeth as well as abnormal teeth
morphology (triangular) of one central incisor. Dental abnor-
malities such as talon cusps, moderate and aberrant tooth
morphology have been described [15].
Our patient had penile hypertrophy as reported previously
in male patients.
Also clitoral hypertrophy was reported to be evident at
birth in female patients, but genitomegaly is not apparent after
puberty. Reproductive abnormalities are common in female
patients. Many have a form of polycystic ovary syndrome.r limbs shows normal bones.
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function [16]. Soliman et al. [17] reported a 2 year old Egyptian
female with BSCL with pubertal LH and FSH responses to
GnRH stimulation. This patient presented with developed
breasts, large clitoris and hypertrophied tibia.
Umbilical hernia or prominence seems to be a consistent
ﬁnding [18]. Our patient had everted umbilicus.
The increased muscle mass or muscular hypertrophy
detected in our patient results from storage of glycogen, tri-
glycerides and creatinine accentuated by anabolic processes
due to hypermetabolism which characterize these patients
[1,4]. Skeletal maturation occurs by the age of 6–8 years. The
joints of the hands, and feet may be enlarged [19] as detected
in our patient.
Our patient had cardiomegaly and hypertrophic cardiomy-
opathy as described in other cases [20,21]. This may be due to
increased anabolism together with excess energy. Our patient
had normal blood pressure; however blood pressure may be
slightly elevated in these patients and is not related to cardiac
hypertrophy [4,21].
Our patient had normal kidney function although different
forms of nephropathy may be associated with lipodystrophy
resulting from diabetes mellitus or hyperlipidemia which may
be associated with this syndrome [4,18].
Dyslipidemia was observed in our patient with elevated tri-
glyceride level and reduced HDL. This is due to inability of
adipocytes to store fat due to abnormal function of glucose
transporters with a low level of intracellular glycerol which
hampers the storage of triglycerides [13]. Hypertriglyceridemia
may result in the appearance of skin xanthomas [4,22] which
were not detected in our patient.
Inability to store triglycerides leads to its abnormal deposi-
tion with enlarged liver and spleen as detected in our patient
which may lead to cirrhosis [4,6]. Also it leads to impaired
insulin secretion, insulin resistance and type 2 diabetes [23].
Although our patient had normal blood sugar and insulin
levels, he has acanthosis nigricans (AN) which is an early clin-
ical expression of insulin resistance [24]. This indicates that he
is starting to get insulin resistance.
In addition to acanthosis nigricans and xanthomas, other
dermatologic manifestations such as hirsutism and thick scalp
hair were reported previously [5]. Hirsutism of the face, neck,
arms and legs may be observed at birth and tends to increase
[5]. Our patient had hirsutism on the back and both legs as well
as thick scalp hair.
The parents of our patient are ﬁrst cousins, with no family
history of similarly affected persons. However consanguinity is
high in Egypt [25] which favors the appearance of autosomal
recessive disorders including this syndrome which is reported
to be transmitted as an autosomal recessive trait.
Four types of BSCL were described and mutations in 2
genes are responsible for 95% of typical cases [26]. In BSCL1
the AGPAT2 gene located in 9p34 was found to be mutated.
This gene encodes the enzyme 1-acylglycerol-3-phosphate acyl
transferase 2 responsible for the synthesis of phosphatidic acid
from lyophosphatidic acid in the pathway of triacylglycerol
synthesis [27]. The 2nd gene found to be mutated is BSCL2
on 11q13 which is associated with BSCL2. This gene encodes
seipin protein and is expressed in most human tissues. Individ-
uals with AGPAT2 mutations mostly originate from Sub-Sah-
aran Africa, Maghreb and occasionally from middle easterncountries while those with BSCL2 gene mutation have been
described worldwide including whites of varying ethnicities
and Middle Eastern Arabs [28]. BSCL1 is a milder variety
which presents in the 2nd decade of life and only 10% of
patients have intellectual impairments [12,29] in contrast to
BSCL2 which presents early in life with a more severe clinical
presentation and 80% have mild to moderate intellectual
impairments [12]. BSCL3 is caused by mutation in CAV1gene
which codes for caveolin protein and is expressed in adipocytes
and plays a role in lipid metabolism [30]. Thus in its mutation
adipocytes are unable to regulate lipid levels [31–33]. Patients
typically have serum creatine kinase (CK) concentrations
between 2.5 and 10 times the upper limit of normal in addition
to features of classic BSCL with low muscle tone [31]. BSCL4
is caused by mutations in PTRF gene which codes for a protein
called polymerase I and transcript release factor which stabi-
lizes and aids in the formation of caveolae. Thus the caveolae
are unable to carry out their role in lipid metabolism. BSCL4
presents with generalized lipodystrophy, distal myopathy,
muscular hypertrophy, insulin resistance and elevated CK lev-
els [33].
So based on the origin and clinical proﬁle our patient most
probably belongs to type 2 as he clinically presents at birth
with typical features with moderate mental retardation and
normal CK.
To conclude: SCGL2 is a multisystemic and progressive dis-
ease. Follow up of patients is important as diabetes mellitus
usually develops in teenage years and is insulin resistant. Also
early onset of liver cirrhosis may occur with signiﬁcant mor-
bidity and mentality. In addition hypertrophic cardiomyopa-
thy and diabetic renal failure are potentially lethal
complications. So early diagnosis and diet control can bring
about a favorable outcome.
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